Akari Therapeutics plc ADS (NASDAQ: AKTX) last traded at $7.85, up 0.77% on the session. The quote above updates while this page is open; the figures below are drawn from Akari Therapeutics plc ADS’s own filings and are restated only when a new one is published.
Akari Therapeutics plc ADS trades on NASDAQ under the ticker AKTX. Its market capitalisation is $1.22 trillion.
Valuation measures for Akari Therapeutics plc ADS, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.22T |
|---|---|
| Enterprise value | $1.22T |
| Price / book | 65754.47 |
| Beta | 1.81 |
Trailing-twelve-month figures tagged in Akari Therapeutics plc ADS's XBRL filings with the SEC.
| Net income (TTM) | -$30.96M |
|---|---|
| EPS (TTM) | $0.00 |
| Return on equity | -166.50% |
| Cash | $7.69M |
Range and volume for AKTX over the past 52 weeks.
| 52-week high | $49.60 |
|---|---|
| 52-week low | $3.02 |
| Volume | 10.7K |
| Average volume | 688.5K |
| Previous close | $7.79 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.